Evidence map›Paper›PMID 37741803›Full record

ArticleAmerican journal of surgery2024

Barriers and facilitators to measuring patient reported outcomes in an academic breast cancer clinic: An application of the RE-AIM framework.

Nicole M Mott, Victoria Huynh, Sudheer Vemuru, Hannah J Parris, Kathryn Colborn, Gretchen Ahrendt, Nicole Christian, Simon Kim, Daniel D Matlock, Ethan Cumbler and 1 more

Abstract read
In one paragraph

Article in American journal of surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nicole M MottUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA.
Victoria HuynhUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA.
Sudheer VemuruUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA.
Hannah J ParrisUniversity of Colorado Anschutz Medical Campus, Department of Medicine, Aurora, CO, USA.
Kathryn ColbornUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA; University of Colorado Cancer Center, Aurora, CO, USA.
Gretchen AhrendtUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA; University of Colorado Cancer Center, Aurora, CO, USA.
Nicole ChristianUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA; University of Colorado Cancer Center, Aurora, CO, USA.
Simon KimUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA.
Daniel D MatlockUniversity of Colorado Anschutz Medical Campus, Department of Medicine, Aurora, CO, USA; VA Eastern Colorado Geriatric Research Education and Clinical Center, Denver, CO, USA.
Ethan CumblerUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA; University of Colorado Anschutz Medical Campus, Department of Medicine, Aurora, CO, USA.
Sarah E A TevisUniversity of Colorado Anschutz Medical Campus, Department of Surgery, Aurora, CO, USA; University of Colorado Cancer Center, Aurora, CO, USA. Electronic address: sarah.tevis@cuanschutz.edu.

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Paul Calabresis Award in Clinical Oncology ResearchK12CA086913 · NCI · UNIVERSITY OF COLORADO DENVER · PI VIRGINIA F. BORGES, Jill E Slansky · 2000 to 2026
$17.8M
NCI NIH HHS K12 CA086913NCI NIH HHS P30 CA046934
6 · The paper itself

Abstract

backgroundPatient reported outcome measures (PROMs) are important for patient-centered, value-based care; however, implementation into surgical practice remains limited. We aimed to demonstrate feasibility of measuring PROMs in an academic breast cancer clinic.

methodsWe conducted a pilot study implementing the patient-reported outcome measure BREAST-Q among patients with Stage 0-III breast cancer at a single institution from 06/2019-03/2023 using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Barriers and facilitators were characterized. Survey completion was assessed pre-operatively and up to 12 months post-operatively.

resultsBarriers included limited time and lack of incorporation into the electronic medical record. Facilitators included utilizing trained team members and an automated workflow. Among eligible patients, 74% completed BREAST-Q at 2-weeks post-operatively and 55% at 12 months post-operatively.

conclusionsWe describe the implementation of a PROM using the RE-AIM framework, highlighting facilitators and barriers that may assist others in collecting patient-reported outcome data.

Indexed as

Breast NeoplasmsFemaleHumansPatient Reported Outcome MeasuresPatientsPilot ProjectsSurveys and QuestionnairesBreast cancerBREAST-QImplementationPatient reported outcome measuresPatient reported outcomesRE-AIM

Identifiers

PMID37741803
PMCPMC11044988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.